These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 18418279)

  • 41. Disability in patients with Menière's disease following the use of two different treatment modalities: betahistine and intratympanic gentamicin.
    Enrique-Gonzaleza A; Sánchez-Ferrándiz N; Pérez-Fernández N
    Rev Laryngol Otol Rhinol (Bord); 2008; 129(4-5):249-54. PubMed ID: 19408504
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A comparison of two methods of using transtympanic electrocochleography for the diagnosis of Meniere's disease: click summating potential/action potential ratio measurements and tone burst summating potential measurements.
    Gibson WP
    Acta Otolaryngol Suppl; 2009 Feb; (560):38-42. PubMed ID: 19221905
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Posterior fossa meningiomas presenting with Ménière's-like symptoms: case report.
    Coelho DH; Roland JT; Golfinos JG
    Neurosurgery; 2008 Nov; 63(5):E1001; discussion E1001. PubMed ID: 19005363
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Amplitude and area ratios of summating potential/action potential (SP/AP) in Meniere's disease.
    Baba A; Takasaki K; Tanaka F; Tsukasaki N; Kumagami H; Takahashi H
    Acta Otolaryngol; 2009 Jan; 129(1):25-9. PubMed ID: 19003588
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The limits of stability in patients with Ménière's disease.
    Sevilla-Garcia MA; Boleas-Aguirre MS; Perez-Fernandez N
    Acta Otolaryngol; 2009 Mar; 129(3):281-8. PubMed ID: 18720065
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Non-surgical management of Meniere's disease.
    DERLACKI EL
    Trans Am Laryngol Rhinol Otol Soc; 1954; 4(58th Meeting):144-60. PubMed ID: 14373807
    [No Abstract]   [Full Text] [Related]  

  • 47. Evaluation of quality of life after intratympanic streptomycin injection in patients with Ménière's disease.
    Jung J; Chun J; Kim N; Kim Y; Lee WS
    Otol Neurotol; 2008 Sep; 29(6):816-23. PubMed ID: 18617871
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hearing results following intratympanic gentamicin perfusion for Ménière's disease.
    Kyrodimos E; Aidonis I; Sismanis A
    J Laryngol Otol; 2009 Apr; 123(4):379-82. PubMed ID: 18954493
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The intravestibular source of the vestibular aqueduct: Its structure and pathology in Ménière's disease.
    Michaels L; Soucek S; Linthicum F
    Acta Otolaryngol; 2009 Jun; 129(6):592-601. PubMed ID: 18720071
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A replication study on proposed candidate genes in Ménière's disease, and a review of the current status of genetic studies.
    Hietikko E; Kotimäki J; Okuloff A; Sorri M; Männikkö M
    Int J Audiol; 2012 Nov; 51(11):841-5. PubMed ID: 22934933
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hearing loss and vestibular function correlation in Menière's disease patients.
    Boleas-Aguirre MS; Palomar-Asenjo V; Sánchez-Ferrándiz N; Pérez N
    Rev Laryngol Otol Rhinol (Bord); 2008; 129(4-5):255-8. PubMed ID: 19408505
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Straightening out Peyronie's: a medical and surgical approach to the patient.
    Trussell JC; Brien JC
    Can J Urol; 2008 Jun; 15(3):4047-55. PubMed ID: 18570708
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Treatment of labyrinthine vertigo by acetazolamide; comparative trials with chlorpromazine & heparin].
    TARLE Y
    Ann Otolaryngol; 1957 Dec; 74(12):986-92. PubMed ID: 13509407
    [No Abstract]   [Full Text] [Related]  

  • 54. [Clinical update on non-surgical management of vertigo].
    Tong MC; Gao H
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Dec; 30(6):736-40. PubMed ID: 19180926
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vestibular drop attack secondary to Meniere's disease results from unstable otolithic function.
    Ozeki H; Iwasaki S; Murofushi T
    Acta Otolaryngol; 2008 Aug; 128(8):887-91. PubMed ID: 18607945
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Survey of the most recent pharmacotherapy for Meniere's syndrome].
    OZAWA R; MUTO J
    Chiryo; 1961 Sep; 43():1576-84. PubMed ID: 13731837
    [No Abstract]   [Full Text] [Related]  

  • 57. Comparable efficacy and tolerability between twice daily and three times daily betahistine for Ménière's disease.
    Ganança MM; Caovilla HH; Ganança FF
    Acta Otolaryngol; 2009 May; 129(5):487-92. PubMed ID: 18615332
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of low-level laser therapy in Ménière's disease: a pilot study of 10 patients.
    Teggi R; Bellini C; Fabiano B; Bussi M
    Photomed Laser Surg; 2008 Aug; 26(4):349-53. PubMed ID: 18665761
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diagnostic test validation: cochlear hydrops analysis masking procedure in Ménière's disease.
    Ordóñez-Ordóñez LE; Rojas-Roncancio E; Hernández-Alarcón V; Jaramillo-Safón R; Prieto-Rivera J; Guzmán-Durán J; Lora-Falquez J; Escobar M; Angulo-Martínez ES
    Otol Neurotol; 2009 Sep; 30(6):820-5. PubMed ID: 19638943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.